YOLFTbeta
Oncolytics Biotech Inc

Oncolytics Biotech Inc

ONCY · NASDAQ · Healthcare / Biotechnology

0.37USD-0.00 (-0.54%)

Price History

Full chart

Market Stats

Previous Close0.372
Open0.38
Day Range0.34 – 0.39
52-Week Range0.6419 – 1.47
Volume1.26M
Market Cap84.54M
P/E (TTM)0.00
Forward P/E45.45
EPS-0.35
Dividend Yield0.00%
Beta1.15
50-Day Avg0.7994
200-Day Avg0.9161

About

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal ("GI") tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jared Kelly J.D., L.L.M.
  • Employees29
  • Headquarters4350 Executive Drive, San Diego, CA, United States, 92121, USA
  • Websitehttps://oncolyticsbiotech.com

Leadership

  • Mr. Jared Kelly J.D., L.L.M.CEO & Director · b. 1986
  • Mr. Kirk J. Look C.A., CPAChief Financial Officer · b. 1972
  • Dr. Thomas C. Heineman M.D., Ph.D.Chief Medical Officer · b. 1959
  • Mr. John McAdoryChief Operating Officer · b. 1977
  • Ms. Allison Hagerman P.Eng., P.M.P.Chief Technology Officer · b. 1984
  • Jon PattonDirector of Investor Relations & Communication
  • Mr. Andrew P. AromandoChief Business Officer · b. 1970
  • Yujun WuVP & Head of Biostatistics
  • Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.Consultant

Financials

Income Statement

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1310.00K0208.87K313.31K699.76K783.46K0000004.85M0000000000000
Growth (%)-+30999900.00%-100.00%-+50.00%+123.35%+11.96%-100.00%-------100.00%------------
Cost of Revenue-3.18M00000004.31M226.01K4.19M95.10K4.85M128.87K163.90K180.41K162.23K90.77K95.38K485.57K332.65K360.57K301.11K298.59K87.00K70.00K
Gross Profit1310.00K0208.87K313.31K699.76K783.46K00-4.31M-226.01K-4.19M-5.33M-109.09K-128.87K-163.90K-180.41K-162.23K-90.77K-95.38K-485.57K-332.65K-360.57K-301.11K-298.59K-87.00K-70.00K
Gross Margin100.00%100.00%-100.00%100.00%100.00%100.00%-------2.25%-------------
Operating Expense577.37K4.96M7.14M6.96M6.93M14.03M14.10M15.50M16.85M13.76M16.78M15.85M23.99M36.58M23.77M18.66M13.74M15.13M15.51M16.57M19.66M25.13M25.87M19.54M25.17M25.45M28.66M
Operating Income-577.37K-4.65M-7.14M-6.75M-6.62M-13.33M-13.31M-15.50M-16.85M-18.07M-17.00M-20.04M-29.32M-36.69M-23.90M-18.82M-13.92M-15.29M-15.61M-16.66M-20.14M-25.46M-26.23M-19.84M-25.47M-25.54M-28.73M
Operating Margin-57737000.00%-1498.60%--3232.38%-2112.40%-1905.23%-1699.19%-------756.22%-------------
EBITDA-575.69K-4.44M-6.67M-6.18M-5.95M-12.58M-12.46M-14.53M-15.83M-17.66M-16.75M-19.04M-29.23M-36.58M-23.77M-18.66M-13.74M-13.80M-15.26M-17.18M-19.66M-25.37M-25.78M-19.55M-25.17M-25.45M-28.66M
EBITDA Margin-57569100.00%-1432.41%--2957.46%-1900.62%-1797.80%-1589.94%-------753.96%-------------
Net Income-574.46K-3.61M-6.17M-6.09M-8.54M-12.96M-12.78M-14.30M-15.64M-17.55M-17.00M-19.97M-29.04M-36.37M-23.53M-18.62M-13.72M-15.14M-15.62M-17.04M-45.55M-22.50M-26.30M-18.30M-20.92M-22.79M-28.76M
Net Income Margin-57446200.00%-1165.53%--2916.44%-2727.07%-1851.52%-1631.47%-------749.73%-------------
R&D486.66K3.69M5.12M4.28M3.31M7.11M9.31M10.80M11.32M13.35M12.15M12.19M23.84M31.40M18.51M13.82M8.60M9.77M9.39M9.42M10.82M12.95M12.92M11.37M13.35M15.44M13.31M
R&D as % of Total Revenue48666200.00%1190.26%-2050.94%1057.82%1015.78%1188.19%------647.27%-------------
Interest Expense0000000000000000000000138.43K528.00K---
Interest Expense % of Total Revenue0.00%0.00%-0.00%0.00%0.00%0.00%------0.00%-------------

Balance Sheet

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.16M21.66M19.07M17.97M26.05M39.49M46.29M33.57M30.78M13.99M37.27M44.43M36.02M22.08M28.22M17.19M27.38M14.76M18.15M14.87M19.66M34.35M45.88M37.33M38.82M20.19M10.40M
Total Liabilities236.10K1.74M3.12M1.41M1.03M1.10M1.84M2.77M2.82M4.53M4.43M2.50M6.50M7.29M6.01M3.37M2.71M4.07M9.87M8.67M19.77M9.59M9.78M10.83M11.26M14.20M15.62M
Total Equity6.93M19.92M15.95M16.56M25.02M38.39M44.45M30.80M23.48M9.45M31.37M41.93M29.52M14.79M22.21M13.82M24.67M10.69M8.28M6.20M-107.89K24.75M36.10M26.50M27.56M5.98M-5.21M
Cash4.55M17.62M14.97M8.32M2.64M12.41M3.51M3.49M6.72M7.43M33.98M39.30M32.92M19.32M25.22M14.15M24.02M12.03M11.84M13.70M14.15M31.22M41.26M11.67M34.91M15.94M7.14M
Total Debt150.00K150.00K150.00K150.00K150.00K150.00K150.00K150.00K--------0---506.28K402.06K655.00K373.00K423.00K1.06M772.51K
Net Debt-4.40M-17.47M-14.82M-8.17M-2.49M-12.26M-3.36M-3.34M-6.72M-7.43M-33.98M-39.30M-32.92M-19.32M-25.22M-14.15M-24.02M-12.03M-11.84M-13.70M-13.64M-30.82M-40.61M-11.29M-34.49M-14.88M-6.37M

Cash Flow

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-534.35K-3.16M-4.27M-7.26M-5.48M-9.22M-11.05M-12.16M-13.57M-15.29M-16.06M-17.88M-22.54M-34.26M-24.44M-19.68M-15.03M-12.48M-14.89M-11.92M-19.91M-22.07M-22.43M-17.21M-21.44M-19.88M-20.11M
Investing Cash Flow-70.26K-372.82K-585.51K-1.20M-16.21M-4.50M-16.62M11.89M4.68M12.54M4.16M-2.06M1.41M-158.85K-287.25K-182.79K-137.56K-51.35K1.98M-107.47K-10.90K-29.00K-286.00K-15.03M15.24M-174.00K-6.00K
Financing Cash Flow5.15M16.60M2.21M1.80M16.00M23.50M18.78M241.40K12.11M3.46M37.05M27.29M14.82M20.85M30.40M9.04M23.67M956.13K12.81M13.30M21.02M39.77M33.02M8.99M24.12M5.03M14.12M
Capital Expenditure19.97K48.56K585.51K1.05M1.10M15.23K61.31K35.84K944.72K111.58K9.32K81.85K257.79K126.41K254.83K152.75K108.27K23.53K105.77K107.47K10.90K29.00K286.00K40.52K6.03K174.00K6.00K
Free Cash Flow-554.32K-3.21M-4.86M-8.31M-6.57M-9.24M-11.11M-12.19M-14.51M-15.40M-16.07M-17.96M-22.80M-34.38M-24.70M-19.83M-15.14M-12.50M-15.00M-12.03M-19.92M-22.10M-22.72M-17.25M-21.45M-20.06M-20.12M
Dividends Paid-0000000000000000000-------
FCF to OCF103.74%101.54%113.70%114.50%120.02%100.17%100.55%100.29%106.96%100.73%100.06%100.46%101.14%100.37%101.04%100.78%100.72%100.19%100.71%100.90%100.05%100.13%101.27%100.24%100.03%100.88%100.03%
Dividend Paid to FCF-0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-------

Earnings

Report DateJun 30, 2002Mar 31, 2003Aug 5, 2003Nov 3, 2003Mar 8, 2004Apr 27, 2004Aug 5, 2004Oct 26, 2004Mar 4, 2005Apr 27, 2005Jul 27, 2005Oct 26, 2005Mar 3, 2006Apr 26, 2006Jul 26, 2006Nov 3, 2006Mar 2, 2007Apr 27, 2007Jul 27, 2007Oct 30, 2007Mar 6, 2008Apr 30, 2008Jul 29, 2008Nov 4, 2008Mar 4, 2009May 5, 2009Jul 29, 2009Nov 5, 2009Mar 9, 2010May 12, 2010Jul 29, 2010Nov 10, 2010Mar 17, 2011May 12, 2011Jul 28, 2011Nov 10, 2011Mar 15, 2012May 10, 2012Aug 2, 2012Nov 8, 2012Mar 14, 2013May 9, 2013Aug 1, 2013Nov 7, 2013Mar 13, 2014May 8, 2014Aug 7, 2014Nov 6, 2014Mar 16, 2015May 7, 2015Aug 6, 2015Nov 5, 2015Mar 11, 2016May 6, 2016Aug 4, 2016Nov 3, 2016Mar 10, 2017May 5, 2017Aug 3, 2017Nov 8, 2017Mar 9, 2018May 11, 2018Aug 3, 2018Nov 12, 2018Mar 8, 2019May 3, 2019Aug 13, 2019Nov 12, 2019Mar 5, 2020May 8, 2020Aug 4, 2020Nov 11, 2020Mar 5, 2021May 7, 2021Aug 6, 2021Nov 5, 2021Mar 2, 2022May 5, 2022Aug 11, 2022Nov 7, 2022Mar 3, 2023May 5, 2023Aug 14, 2023Nov 3, 2023Mar 7, 2024May 9, 2024Aug 1, 2024Nov 12, 2024Mar 7, 2025May 7, 2025Aug 8, 2025Nov 12, 2025Mar 5, 2026May 14, 2026Aug 12, 2026Nov 11, 2026
EPS Estimate---------1.15---0.85---------0.95-1.04-0.90-1.19-1.05-0.87-0.76-0.75-0.55-0.73-0.78-0.85-0.89-0.75-0.76-0.89-0.96-1.20-1.16-1.21-1.05-0.87-0.82-0.65-0.81-0.66-0.66-0.57-0.57-0.38-0.38-0.33-0.38-0.38-0.28-0.28-0.28-0.38-0.28-0.38-0.28-0.190.05-0.28-0.24-0.29-0.25-0.20-0.14-0.19-0.14-0.13-0.15-0.15-0.12-0.12-0.13-0.14-0.10-0.11-0.10-0.14-0.11-0.11-0.15-0.11-0.11-0.11-0.13-0.09-0.08-0.07-0.07-0.07-0.07-0.06
EPS Actual-0.40-0.32-1.19-0.50-0.43-0.71-0.77-0.76-1.64-0.57-0.69-0.85-0.97-0.68-0.70-0.80-1.12-0.87-0.77-0.83-0.85-0.76-1.24-0.95-0.85-0.85-0.85-0.47-0.85-0.66-0.66-0.66-1.14-0.57-0.95-0.85-1.52-1.04-1.24-1.14-1.04-0.76-0.57-0.66-0.66-0.57-0.47-0.47-0.38-0.38-0.28-0.19-0.28-0.28-0.19-0.28-0.47-0.28-0.28-0.19-0.38-0.28-0.27-0.20-0.28-0.27-0.26-0.16-0.260.12-0.16-0.16-0.22-0.13-0.13-0.09-0.14-0.12-0.09-0.08-0.15-0.10-0.11-0.13-0.05-0.09-0.10-0.12-0.10-0.08-0.07-0.140.00-0.11-0.08-
Surprise---------42.61%--0.00%--------10.53%26.92%-37.78%20.17%19.05%2.30%-11.84%37.33%-54.55%9.59%15.38%22.35%-28.09%24.00%-25.00%4.49%-58.33%13.33%-6.90%5.79%0.95%12.64%30.49%-1.54%18.52%13.64%28.79%17.54%33.33%0.00%26.32%42.42%26.32%26.32%32.14%0.00%-67.86%26.32%0.00%50.00%-35.71%-47.37%-640.00%28.57%-16.67%6.90%-4.00%20.00%-85.71%163.16%-14.29%-23.08%-46.67%13.33%-8.33%25.00%-7.69%14.29%10.00%27.27%-50.00%28.57%0.00%-18.18%66.67%18.18%9.09%-9.09%23.08%11.11%12.50%-100.00%100.00%-57.14%-14.29%-
Timing--------Pre-market------------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap84.54M
Enterprise Value87.29M
Trailing P/E0.00
Forward P/E45.45
Price / Sales58.60
Price / Book1055.04
EPS-0.35
Book Value-0.049
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-37.65M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-769.06%
Return on Assets-211.24%
Shares Outstanding127.51M
Shares Float125.05M
Beta1.15
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 6 analystsTarget 4.14
  • Strong Buy
    1
  • Buy
    4
  • Hold
    1

Ownership Breakdown

Institutions
3.30%
Insiders
2.05%
Retail / Other
94.65%

Top Institutional Holders

  • Marshall Wace Asset Management Ltd
    859.83K0.67%
  • Renaissance Technologies Corp
    715.84K0.56%
  • Sandbox Financial Partners, LLC
    400.00K0.31%
  • SEEDS INVESTOR LLC
    258.31K0.20%
  • International Assets Investment Management, LLC
    201.26K0.16%
  • Connective Capital Management LLC
    185.71K0.15%
  • Tocqueville Asset Management L.P.
    149.00K0.12%
  • Everhart Financial Group, Inc.
    140.90K0.11%
  • PFG Investments, LLC
    128.30K0.10%
  • XTX Topco Ltd
    109.76K0.09%
  • Doliver Capital Advisors, Inc.
    100.00K0.08%
  • LPL Financial Corp
    78.90K0.06%
  • Franklin Templeton Inc
    69.84K0.05%
  • Geode Capital Management, LLC
    66.94K0.05%
  • CIBC World Markets Inc.
    60.30K0.05%
  • UBS Group AG
    50.56K0.04%
  • Head & Associates, LLC
    44.70K0.04%
  • BMO Capital Markets Corp.
    44.48K0.03%

Top Fund Holders

  • Invesco NASDAQ Future Gen 200 ETF
    107.52K0.08%
  • Fidelity Nasdaq Composite Index
    66.94K0.05%

Stock Splits

  • May 25, 201810:95